avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cdc5l | mm10_v2_chr17_-_45433682_45433709 | -0.31 | 6.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_109990430 Show fit | 2.06 |
ENSMUST00000001720.7
ENSMUST00000143741.1 |
tyrosine aminotransferase |
|
chr2_+_58755177 Show fit | 1.99 |
ENSMUST00000102755.3
|
uridine phosphorylase 2 |
|
chr5_-_87591582 Show fit | 1.64 |
ENSMUST00000031201.7
|
sulfotransferase family 1E, member 1 |
|
chr14_+_66635251 Show fit | 1.52 |
ENSMUST00000159365.1
ENSMUST00000054661.1 ENSMUST00000159068.1 |
adrenergic receptor, alpha 1a |
|
chr3_+_138217814 Show fit | 1.21 |
ENSMUST00000090171.5
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
chr4_-_119383732 Show fit | 0.78 |
ENSMUST00000044781.2
ENSMUST00000084307.3 |
coiled-coil domain containing 30 |
|
chr5_-_86518578 Show fit | 0.77 |
ENSMUST00000134179.1
|
transmembrane protease, serine 11g |
|
chr7_-_103741322 Show fit | 0.74 |
ENSMUST00000051346.2
|
olfactory receptor 629 |
|
chr2_+_126034967 Show fit | 0.72 |
ENSMUST00000110442.1
|
fibroblast growth factor 7 |
|
chr5_+_92387846 Show fit | 0.67 |
ENSMUST00000138687.1
ENSMUST00000124509.1 |
ADP-ribosyltransferase 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 2.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 2.0 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.5 | 1.5 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 0.7 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 0.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.7 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.0 | 0.7 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.6 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 1.5 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.7 | GO:0032982 | muscle myosin complex(GO:0005859) myosin filament(GO:0032982) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.4 | 2.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 1.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.4 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |